Neil P. Balmert

Recent Matters

• Represented public companies in various domestic and cross-border transactions, including the recent $1.4 billion acquisition of a world-class CPU and technology company.
• Represented target public company in public/public all stock tax-free reorganization.
• Represented public company in its acquisition of a leader in long-term post-acute care software, for $750 million.
• Represented private target in its acquisition by public company in a tax-free reorganization valued at $500 million.
• Represented public target in a tender offer valued at $1.8 billion.
• Represented private target in its $550 million sale to public company. 
• Represented private target in its $300 million acquisition by public company.
• Represented a leading provider of supply chain optimization software solutions in its acquisition by private equity firm.
• Represented a developer of cancer-focused immunotherapy solutions in its $125 million acquisition by public company.
• Represented a construction and engineering software solutions provider in its acquisition by public company.
• Represented limited partners on rollover of their equity in connection with the sale of major league baseball franchise. 
• Represented owner and operator of publicly-held restaurant chain in its $1.1 billion going private transaction.
• Represented a life sciences research tools company in its $315 million acquisition by public company.